BLANDIZZI, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 30.189
AS - Asia 13.788
EU - Europa 11.700
SA - Sud America 2.014
AF - Africa 669
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 14
Totale 58.432
Nazione #
US - Stati Uniti d'America 29.356
SG - Singapore 4.197
CN - Cina 4.112
IT - Italia 3.926
HK - Hong Kong 2.395
SE - Svezia 2.027
BR - Brasile 1.699
DE - Germania 1.247
BG - Bulgaria 1.063
VN - Vietnam 825
GB - Regno Unito 763
TR - Turchia 670
CA - Canada 649
UA - Ucraina 548
RU - Federazione Russa 521
FI - Finlandia 500
KR - Corea 402
IN - India 343
CI - Costa d'Avorio 266
AT - Austria 240
FR - Francia 239
CH - Svizzera 192
JP - Giappone 139
BD - Bangladesh 108
AR - Argentina 95
MX - Messico 95
NG - Nigeria 95
SN - Senegal 94
NL - Olanda 88
BE - Belgio 83
IQ - Iraq 83
ID - Indonesia 81
PL - Polonia 66
PK - Pakistan 62
UZ - Uzbekistan 57
ZA - Sudafrica 57
AU - Australia 50
EC - Ecuador 49
VE - Venezuela 49
SA - Arabia Saudita 45
CO - Colombia 37
ES - Italia 37
MY - Malesia 31
MA - Marocco 30
EG - Egitto 25
PH - Filippine 25
AZ - Azerbaigian 24
PY - Paraguay 24
PT - Portogallo 23
PE - Perù 22
JO - Giordania 21
KE - Kenya 21
AE - Emirati Arabi Uniti 20
CL - Cile 20
LT - Lituania 19
BJ - Benin 16
IR - Iran 14
TH - Thailandia 14
TN - Tunisia 14
CZ - Repubblica Ceca 13
GR - Grecia 13
IL - Israele 13
JM - Giamaica 13
NP - Nepal 13
EU - Europa 12
IE - Irlanda 12
PA - Panama 12
TW - Taiwan 12
KG - Kirghizistan 11
KZ - Kazakistan 11
OM - Oman 11
HN - Honduras 10
TT - Trinidad e Tobago 10
AL - Albania 9
DO - Repubblica Dominicana 9
PS - Palestinian Territory 9
UY - Uruguay 9
BY - Bielorussia 8
CR - Costa Rica 8
ET - Etiopia 8
LB - Libano 8
NZ - Nuova Zelanda 8
RO - Romania 8
AO - Angola 7
DK - Danimarca 7
DZ - Algeria 7
NO - Norvegia 7
BB - Barbados 6
BO - Bolivia 6
LV - Lettonia 6
GE - Georgia 5
HR - Croazia 5
KH - Cambogia 5
QA - Qatar 5
RS - Serbia 5
SI - Slovenia 5
SY - Repubblica araba siriana 5
BW - Botswana 4
CG - Congo 4
GH - Ghana 4
Totale 58.356
Città #
Woodbridge 3.259
Ashburn 2.995
Ann Arbor 2.757
Fairfield 2.362
Hong Kong 2.360
Singapore 2.263
Houston 2.044
Chandler 1.942
Santa Clara 1.567
Dallas 1.420
Sofia 1.061
Milan 905
Shanghai 904
Seattle 894
Beijing 870
Wilmington 843
Cambridge 806
Serra 796
New York 680
Jacksonville 649
Ottawa 536
Hefei 509
Boardman 499
Princeton 456
Los Angeles 428
Lawrence 406
Izmir 392
Seoul 375
Medford 359
Nanjing 315
Abidjan 266
Des Moines 246
Dong Ket 213
Florence 213
London 208
Istanbul 194
Dearborn 190
Bern 175
Vienna 171
Buffalo 157
Munich 142
São Paulo 135
Redondo Beach 132
Frankfurt am Main 127
Rome 126
Ho Chi Minh City 125
Nanchang 121
Council Bluffs 116
Jüchen 113
Redwood City 112
Tokyo 112
Pisa 111
Bremen 107
The Dalles 107
San Diego 105
Columbus 101
Dakar 94
Lagos 90
Helsinki 81
Brussels 80
Falls Church 77
Hanoi 77
Turku 76
Lancaster 71
Kunming 69
Rio de Janeiro 69
Washington 66
Ogden 65
Norwalk 64
Chicago 63
Marseille 63
Shenyang 60
Hebei 59
Tianjin 58
Boulder 56
Changsha 53
Düsseldorf 53
Pune 49
Phoenix 48
San Jose 48
Tashkent 48
Belo Horizonte 45
Jakarta 45
Jiaxing 45
Toronto 43
Warsaw 42
Curitiba 40
Guangzhou 39
Fuzhou 38
Auburn Hills 35
San Francisco 31
Lucca 30
Hangzhou 29
Quanzhou 29
Baghdad 28
Porto Alegre 28
Brasília 27
Kent 26
Nürnberg 26
Bologna 25
Totale 41.865
Nome #
Derivati isoindolici come attivatori di AMPK 504
Preparation of isoindoline derivatives for use as AMPK activators 317
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 286
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 281
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 257
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 248
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 247
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 244
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 238
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 233
Derivati benzofuranici come attivatori di AMPK 226
Effects of suramin on gastric ulceration and EGF content of submandibular glands 222
A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties 217
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 215
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis 214
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID) 211
Fisiopatologia e farmacologia del vomito 210
Functional evidence that alpha-2A-adrenoceptors are responsible for anti-lipolysis in human abdominal cells 210
Alpha-2 adrenoceptors and gastric secretion in dogs: The role of gastrin 209
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 209
Excitatory and inhibitory cholinergic effects of yohimbine on isolated guinea-pig small intestine 208
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 206
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 205
Altered expression pattern of molecular factors involved in colonic smooth muscle functions : an immunohistochemical study in patients with diverticular disease 204
Connective remodelling in the colonic neuromuscular compartment of patients with ulcerative colitis 203
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis 201
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 199
Alpha-2 adrenoceptors and gastric secretion in dogs: the role of gastrin 198
Alpha-2A adrenoceptor subtypes modulate cholinergic contractile activity of guinea-pig ileum 197
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 197
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 197
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 196
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 193
Periodontal tissue disposition of azithromycin 192
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 192
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 191
Role of a2-adrenoceptors on gastrin release in the dog 190
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 189
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 188
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis 188
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 187
Targeting enteric neuroplasticity: Diet and bugs as new key factors 187
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 187
Quinolonecarboxylic acid derivatives as GABA-A receptor antagonists 186
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 186
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 185
GABA-A-mediated gastrin release induced by baclofen in the isolated vascularly perfused rat stomach 184
Gabapentin-induced severe myopathy: a case report 184
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 183
Molecular cloning of the canine gastrin/CCK-B receptor gene 182
Characterization of mechanisms accounting for COX-2-mediated proliferative actions of gastrin on human colon cancer cells 182
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 182
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 181
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 181
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 181
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 180
Alteration of endogenous purinergic modulation of tracheal neurotransmission in sensitised guinea-pigs 179
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 179
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 179
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 179
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 179
A tonic inhibitory control of rat pepsin secretion is mediated by central GABA-A receptors 179
Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders 178
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 178
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 177
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 177
Modulation of gastric acid secretion by peripheral presynaptic alpha-2 adrenoceptors at both sympathetic and parasympathetic pathways 176
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials 176
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 176
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 176
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 176
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 175
Effects of a bicarbonate-alkaline mineral water on gastric functions and functional dyspepsia: a preclinical and clinical study 174
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan. 174
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 174
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 173
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 173
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 172
PERIODONTAL TISSUE DISTRIBUTION OF CEFPODOXIME PROXETIL AND EFFICACY IN ACUTE ODONTOGENIC INFECTIONS 171
Peripheral 2-hydroxy-saclofen-sensitive GABA-B receptors mediate both vagal-dependent and vagal-independent acid secretory responses in rats 171
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 171
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 171
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 171
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 170
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 170
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 170
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 170
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 170
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 170
Colonic smooth muscle cells and interstitial cells of Cajal in diverticular disease 168
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion 168
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 168
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 168
The effects of GABA agonists and antagonists on rat gastric acid secretion 167
Healthy volunteers and early phases of clinical experimentation 167
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 167
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 166
Allopurinol adherence among patients with gout: an Italian general practice database study 166
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 166
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 165
Totale 19.460
Categoria #
all - tutte 170.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.863


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.355 0 0 0 0 0 175 210 293 365 355 213 744
2021/20224.820 115 278 190 359 871 681 144 269 220 158 259 1.276
2022/20236.157 736 833 401 592 682 848 89 457 1.051 42 387 39
2023/20244.461 575 467 549 303 639 774 170 164 70 118 192 440
2024/202513.205 67 509 183 810 1.208 1.356 1.075 647 1.332 1.826 1.440 2.752
2025/20268.181 1.077 1.766 1.711 991 1.412 1.224 0 0 0 0 0 0
Totale 59.400